These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2429426)

  • 1. Involvement of natriuretic hormones and Na+ transport in the antihypertensive action of canrenone.
    Hannaert P; de Mendonca M; Grichois ML; Nazaret C; Abitbol JP; Garay R
    Uremia Invest; 1985-1986; 9(2):195-201. PubMed ID: 2429426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Canrenone: an effective antihypertensive in an experimental model of hypertension in which the active transport of sodium is diminished].
    Grichois ML; de Mendonça M; Wauquier I; Pernollet MG; Thormann B; Devynck MA; Meyer P; Garay RP
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):875-8. PubMed ID: 3099704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of canrenone on the disturbances of cation handling induced by ouabain in macrophages and vascular smooth muscle cells.
    Hannaert P; Thormann B; Garay R
    J Pharmacol Exp Ther; 1986 Dec; 239(3):867-72. PubMed ID: 2432218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of canrenone in a model where endogenous ouabain-like factors are present.
    de Mendonça M; Grichois ML; Pernollet MG; Wauquier I; Trouillet-Thormann B; Meyer P; Devynck MA; Garay R
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):75-83. PubMed ID: 2450260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte Na+, K+ pump inhibition after saline infusion in essentially hypertensive subjects: effects of canrenone administration.
    Boero R; Guarena C; Deabate MC; Rolando B; Rosati C; Quarello F; Piccoli G
    Int J Cardiol; 1989; 25 Suppl 1():S47-52. PubMed ID: 2620996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of canrenone on blood pressure in rats with reduced renal mass.
    Pamnani MB; Whitehorn WV; Clough DL; Haddy FJ
    Am J Hypertens; 1990 Mar; 3(3):188-95. PubMed ID: 2157466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of canrenone with the Na+,K+ pump in human red blood cells.
    Garay RP; Diez J; Nazaret C; Dagher G; Abitbol JP
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):311-5. PubMed ID: 2991778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
    De Mendonca M; Grichois ML; Pernollet MG; Thorman B; Meyer P; Devynck MA; Garay R
    J Hypertens Suppl; 1985 Dec; 3(3):S73-5. PubMed ID: 2856827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
    Tal DM; Karlish SJ
    Mol Pharmacol; 1988 Sep; 34(3):245-9. PubMed ID: 2843743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase.
    Finotti P; Palatini P
    J Pharmacol Exp Ther; 1981 Jun; 217(3):784-90. PubMed ID: 6262496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic response to canrenone of patients with essential hypertension as a function of sodium transport anomalies and ouabain sensitivity of erythrocytes].
    Hannaert P; Laurent S; Girerd X; Safar M; Abitbol JP; Garay R
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1603-7. PubMed ID: 2554840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic agents for the in vivo detection of vascular sodium transport defects in hypertension.
    Haddy FJ; Pamnani MB
    Life Sci; 1987 Dec; 41(25):2685-96. PubMed ID: 2447462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of saline infusion and canrenone on erythrocyte Na+,K+ pump activity.
    Boero R; Guarena C; Deabate MC; Rosati C; Forneris G; Quarello F; Piccoli G
    Kidney Int Suppl; 1988 Sep; 25():S9-11. PubMed ID: 2846942
    [No Abstract]   [Full Text] [Related]  

  • 14. [Membrane activity of canrenone in the normotensive subject: evaluation and significance].
    Ollivier JP; Delamourd L; Leglise D
    Sem Hop; 1981 Mar 8-15; 57(9-10):495-8. PubMed ID: 6261395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na+ transport in primary hypertension.
    Garay R; Rosati C; Meyer P
    Ann N Y Acad Sci; 1986; 488():187-95. PubMed ID: 2437844
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of canrenone on Na+,K+ ATPase activity, arterial pressure and plasma potassium concentration in uremic hemodialyzed patients.
    Quarello F; Boero R; Guarena C; Rosati C; Beltrame G; Colombo P; Berto IM; Aimino M; Formica M; Piccoli G
    Adv Exp Med Biol; 1989; 252():371-6. PubMed ID: 2551145
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase in the basal tone of guinea pig thoracic aorta induced by ouabain is inhibited by spironolactone canrenone and potassium canrenoate.
    Sorrentino R; Cirino G; Calignano A; Mancuso F; Sorrentino L; Andriuoli G; Pinto A
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):519-25. PubMed ID: 8891876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of canrenone on aorta and right ventricle of the rat.
    Cargnelli G; Trevisi L; Debetto P; Luciani S; Bova S
    J Cardiovasc Pharmacol; 2001 May; 37(5):540-7. PubMed ID: 11336105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na+-K+ regulation in cultured vascular smooth muscle cell of the spontaneously hypertensive rat.
    Tamura H; Hopp L; Kino M; Tokushige A; Searle BM; Khalil F; Aviv A
    Am J Physiol; 1986 Jun; 250(6 Pt 1):C939-47. PubMed ID: 2424316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of canrenone on the digitalis site of Na+/K(+)-ATPase in human placental membranes and in erythrocytes.
    Balzan S; Nicolini G; Bellitto L; Ghione S; Biver P; Montali U
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):32-6. PubMed ID: 12827023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.